金沙(8888js-官方JS认证)-Made in China

Be the most trusted biotech company

2024-02-19

ASTRUM-004 Featured on the Cover of Cancer Cell
2024-02-01

Henlius Announces Successful Completion of Phase 1 PK Similarity Clinical Study of Denosumab HLX14
2024-01-25

First International Shipment of HANSIZHUANG
2024-01-17

Results from Clinical Trials of Two Henlius’ Novel Products Released at ASCO GI 2024
2024-01-11

Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
2024-01-05

Cancer Cell Published the Results of ASTRUM-004: HANSIZHUANG Combined with Chemotherapy for the First-line Treatment of sqNSCLC
2024-01-03

Henlius to Release Clinical Data at 2024 ASCO GI
2024-01-02

Expanded Access Policy for HLX42
2023-12-28

HANSIZHUANG Sets Sail in Indonesia Market